Results: All formats performed in a similar manner (r>0.85). The table below shows the results:
Cancer type Nr of Cancers Nr of Normals Cutoff (Units) Sensitivity Specificity
Liver * 15 128 4,900 100% 94%
Pancreatic # 10 50 4,600 100% 95%
Stomach 1st study * 48 40 4,600 90% 98%
Stomach 2nd study * 15 128 4,550 100% 94%
Colorectal & 51 85 4,800 100% 93%
If anyone is not blown away then you don't have a clue. IMO, we will see many collaborations and licenses. You can see why Dr Moro is confident about the future of our company.
Sorry to the naysayers. What you see is what you get. No more no less. SPIN THAT!!!!!!!! You have to be on board now. Those are not small samples and you cannot fudge the data. Also look at the type of cancers. There presently are not any markers
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.